Navigation Links
Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011
Date:8/31/2011

SAN DIEGO, Aug. 31, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences:


  • Stifel Nicolaus 2011 Healthcare ConferenceDate:  

    Wednesday, September 7, 2011Time:  

    1:30pm Eastern Time (10:30am Pacific Time)Place:  

    Four Seasons Hotel in BostonSpeaker:

    Scott Byrd, SVP & Chief Commercial Officer


  • UBS Global Life Sciences ConferenceDate:  

    Tuesday, September 20, 2011Time:  

    11:30am Eastern Time (8:30am Pacific Time)Place:  

    Grand Hyatt Hotel in New York CitySpeaker:

    Ted Schroeder, President & CEO


  • JMP Securities Healthcare ConferenceDate:Wednesday, September 28, 2011Time:9:30am Eastern Time (6:30am Pacific Time)Place:

    The St. Regis Hotel in New York CitySpeaker:

    Ted Schroeder, President & CEOEach presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com on the Investor Relations page.  A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.

    About Cadence Pharmaceuticals, Inc.Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com.Contacts:

    William R. LaRue '/>"/>


    • SOURCE Cadence Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2

    Related medicine technology :

    1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
    2. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
    3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
    4. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
    5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
    6. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
    7. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
    8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
    9. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
    10. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
    11. Oxford Finance Corporation Leads $30 Million Secured Loan Facility for Cadence Pharmaceuticals
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/21/2013)... May 21, 2013 Kepner-Tregoe (KT), the ... that 13-year veteran Chris Geraghty ... experience includes more than 20 years serving the ... manufacturing organizations. He succeeds Ray Baxter ... Kepner-Tregoe,s Chairman of the Board and CEO. ...
    (Date:5/21/2013)... 21, 2013  Armada Health Care (Armada) is ... Armada corporate website ( www.armadahealthcare.com ).  This new ... and first-to-market services and its position as the ... specialty pharmacy industry. The updated website ... business model in delivering an extensive portfolio of ...
    (Date:5/21/2013)... 2013 Hurel Corporation ("Hurel"), a world-leading provider ... platforms, today announced the appointment of James ... Board of Directors. Dr. MacDonald is the former Executive ... Institute ("SPRI"), which was the pharmaceutical development arm of ... Co. in 2009. Over a career that ...
    Breaking Medicine Technology:Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
    ... 2011 Healthpoint today announced the launch of a ... Biotherapeutics, along with an updated brandmark and corporate tagline, ... is designed to communicate the company,s commitment to scientific ... contribute to improved outcomes and quality of life for ...
    ... Md., Feb. 23, 2011 The Cystic Fibrosis Foundation and ... development that targets the defective protein that causes cystic fibrosis, ... The trial was designed to evaluate patients age ... a CF mutation called G551D. The study included 161 patients ...
    Cached Medicine Technology:Healthpoint Launches New Corporate Identity 2Healthpoint Launches New Corporate Identity 3Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 2Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 3
    (Date:5/21/2013)... May 21, 2013 Medical Ministry International ... prestigious 2013 Top-Rated Award by GreatNonprofits , the leading ... excited to be named a Top-Rated 2013 Nonprofit,” says Samuel ... dedication of our over 3000 Volunteers and Staff serving in ... as it came from those that have seen our work ...
    (Date:5/21/2013)... New York, New York (PRWEB) May 21, 2013 ... protecting the rights of victims injured by defective medical devices, ... attorney in the case of the Estate of Fred E. ... Kitsap County (Port Orchard). A May 21, 2013, Bloomberg ... Intuitive Surgical had acted like a “car dealership” in how ...
    (Date:5/21/2013)... TX (PRWEB) May 21, 2013 ContinuCare ... the Texas Department of Aging and Disability Services. After ... and employee interviews, ContinuCare Home Health was found ... The review is part of the Department of Aging ... of aging and disability services, supports and opportunities ...
    (Date:5/21/2013)... HealthSmart continues to grow through strategic ... required the hiring of new talent in several areas, ... announce that Dawn Powell has joined the organization effective ... of Account Management in the Central Region and is ... With extensive client management, employee benefits, and product development ...
    (Date:5/21/2013)... stent, which is a novel stent platform eluting ... the Xience Prime everolimus-eluting stent for the primary ... nine months in the results of an imaging ... BIOFLOW-II substudy used intravascular ultrasound (IVUS) and optical ... and stent apposition at nine months after treating ...
    Breaking Medicine News(10 mins):Health News:Medical Ministry International Recognized as a 2013 Top-rated Nonprofit By GreatNonprofits.org 2Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 2Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 3Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2Health News:New Talent Joins the HealthSmart Account Management Team 2Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2
    ... University School of Medicine in St. Louis, Missouri, have ... lead to treatments for deadliest poisons like Ricin, cholera ... the deadly strains of E. coli bacteria, these toxins ... the Golgi network and endoplasmic reticulum before interrupting protein ...
    ... from Eli Lilly and Company and the ... the genetic mutation that may alter tumour cell proliferation, ... ,The researchers say that they found a ... and ovarian cancers. ,The AKT pathway ...
    ... vineyards and launching an overseas marketing blitz under ... glut and countering New World producers. ,Farm ... wine budget of 1.3 billion euros (1.8 billion dollars) ... huge challenges facing the sector. ,"We are ...
    ... ended the six-year reign of a Japanese champion Wednesday, gobbling ... the annual Nathan's Famous Hot Dog Eating contest. ... streak to the cheers of a crowd of 50,000, according ... dropping out of the event after arthritis of the jaw ...
    ... protein that, in rats, rescues brain cells whose death ... the central nervous system. ,The new molecule, ... of cells that produce the key brain chemical dopamine ... ,Tested on lab rodents engineered to have Parkinson's, ...
    ... at the scene of a variety of tumors is implicated ... in a paper by researchers at The University of ... the Proceedings of the National Academy of Sciences. ... that its actually causing cancer. In this paper we show ...
    Cached Medicine News:Health News:Genetic Mutation That Makes Common Cancers Resistant to Drugs Identified 2Health News:EU Aims to Shake Up Wine Industry With Root-and-branch Reform 2Health News:American Bests Japanese Hot Dog Eating Champion, Sets Record 2Health News:New Oncogene for Brain Cancer 2Health News:New Oncogene for Brain Cancer 3
    Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • Not available with casters • With Tubular Base....
    Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
    Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
    Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
    Medicine Products: